Paediatric UTI pathogens respond well to aminopenicillin, β-lactamase inhibitors
Pathogens behind paediatric febrile urinary tract infections (UTIs) show a satisfactory in vitro susceptibility profile to first-line therapy with a combination of aminopenicillin and β-lactamase inhibitors, a new study has shown.
Paediatric UTI pathogens respond well to aminopenicillin, β-lactamase inhibitors
09 May 2020